WHO ICTRP trial
KARE: Ketamine for reduction of Alcoholic Relapse
EUCTR2015-000222-11-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2015-000222-11-GB |
|---|---|
| Public title | KARE: Ketamine for reduction of Alcoholic Relapse |
| Scientific title | A phase II, randomised, double-blind, placebo- controlled, multi-site, parallel group clinical trial to examine ketamine as a pharmacological treatment for alcohol dependence in an alcohol dependent population. - KARE: Ketamine for reduction of Alcoholic Relapse Version 1 |
| Primary sponsor | University College London |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Severe Alcohol Use Disorder MedDRA version: 21.0 Level: LLT Classification code 10001585 Term: Alcohol abuse chronic System Organ Class: 100000004873 ;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03] |
| Interventions | Trade Name: Ketalar Product Name: Ketalar Pharmaceutical Form: Solution for injection/infusion INN or Proposed INN: Ketamine CAS Number: 6740-88-1 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration… |
| Registration date | Jul 30, 2020 |
| Target size | 96 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: